Please login to the form below

Not currently logged in
Email:
Password:

Icon to set up translational medicine centre in the UK

Expands early phase research presence at new Manchester site

Contract research organisation Icon is expanding its early phase research presence in the UK and setting up a new translational medicine centre.

Based in the Citylabs biomedical centre on the former site of the Manchester Royal Eye Hospital, Icon's Centre of Excellence for Translational Medicine will occupy a 40,000 sq ft site and is due to open before the end of 2013.

At this time Icon will also move the phase I operations of its hospital-based clinical pharmacology unit to Citylabs from its current base on the Manchester Royal Infirmary Campus.

President of Icon Development Solutions Dr Mario Rocci said: “We are pleased to be expanding our early phase development services through the establishment of a Centre of Excellence for Translational Medicine in Citylabs.

“This expansion will enable Icon to increase the capacity of its Clinical Pharmacology Unit in Manchester as well as the scientific services that are essential in providing a world class offering.”

Translational research is a way of conducting scientific research 'from bench to bedside' and also 'from bedside to bench', to ensure the results will be applicable to the relevant patient population 

Along with Icon's Translational Medicine Research Centre, Citylabs be home to a number of other health organisations, including the Central Manchester University Hospitals NHS Foundation Trust, The University of Manchester and commercial research organisations.

Mike Deegan, chief executive of Central Manchester University Hospitals NHS Foundation Trust, said: “This exciting development supports our progress to be the leading hospital for research and patient care in England and Citylabs will strengthen our capability to support the development of new medicines and diagnostics for our patients.

“We are pleased that Icon, who is one of the leaders in early phase trials, is expanding into Citylabs which will help our patients to get early access to leading edge new treatments.”

8th August 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Easier access to medicines in the UK?
Cutting through the NICE value-based assessment consultation to find out what’s at stake...
Exploring MINT: Part 3 - Nigeria
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria....
BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....